These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025
28 results:

  • 1. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal cancer: A Systematic Review and Meta-Analysis.
    Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
    Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA Repair Protein Expression and Oxidative/Nitrosative Stress in Ulcerative Colitis and Sporadic colorectal cancer.
    DE Angelis PM; Dorg L; Pham S; Andersen SN
    Anticancer Res; 2021 Jul; 41(7):3261-3270. PubMed ID: 34230120
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.
    Boige V; Mollevi C; Gourgou S; Azria D; Seitz JF; Vincent M; Bigot L; Juzyna B; Miran I; Gerard JP; Laurent-Puig P
    Int J Cancer; 2019 Dec; 145(11):3163-3172. PubMed ID: 31107542
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bulky DNA adduct levels in normal-appearing colon mucosa, and the prevalence of colorectal adenomas.
    Ho V; Peacock S; Massey TE; Godschalk RW; van Schooten FJ; Ashbury JE; Vanner SJ; King WD
    Biomarkers; 2018 Dec; 23(8):735-741. PubMed ID: 29871536
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. DNA repair protein xpa is differentially expressed in colorectal cancer and predicts better prognosis.
    Feng X; Liu J; Gong Y; Gou K; Yang H; Yuan Y; Xing C
    Cancer Med; 2018 Jun; 7(6):2339-2349. PubMed ID: 29675892
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates colorectal Carcinogenesis and Prognosis.
    Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
    Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas.
    Slyskova J; Korenkova V; Collins AR; Prochazka P; Vodickova L; Svec J; Lipska L; Levy M; Schneiderova M; Liska V; Holubec L; Kumar R; Soucek P; Naccarati A; Vodicka P
    Clin Cancer Res; 2012 Nov; 18(21):5878-87. PubMed ID: 22966016
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. xpa A23G polymorphism and susceptibility to cancer: a meta-analysis.
    Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
    Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.
    Abulí A; Fernández-Rozadilla C; Giráldez MD; Muñoz J; Gonzalo V; Bessa X; Bujanda L; Reñé JM; Lanas A; García AM; Saló J; Argüello L; Vilella A; Carreño R; Jover R; Xicola RM; Llor X; Carvajal-Carmona L; Tomlinson IP; Kerr DJ; Houlston RS; Piqué JM; Carracedo A; Castells A; Andreu M; Ruiz-Ponte C; Castellví-Bel S;
    Br J Cancer; 2011 Sep; 105(6):870-5. PubMed ID: 21811255
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.
    Gil J; Ramsey D; Stembalska A; Karpinski P; Pesz KA; Laczmanska I; Leszczynski P; Grzebieniak Z; Sasiadek MM
    Mol Biol Rep; 2012 Jan; 39(1):527-34. PubMed ID: 21559836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study.
    Marshall A; Altman DG; Holder RL
    BMC Med Res Methodol; 2010 Dec; 10():112. PubMed ID: 21194416
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population.
    Jelonek K; Gdowicz-Klosok A; Pietrowska M; Borkowska M; Korfanty J; Rzeszowska-Wolny J; Widlak P
    J Appl Genet; 2010; 51(3):343-52. PubMed ID: 20720310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.
    Joshi AD; Corral R; Siegmund KD; Haile RW; Le Marchand L; Martínez ME; Ahnen DJ; Sandler RS; Lance P; Stern MC
    Carcinogenesis; 2009 Mar; 30(3):472-9. PubMed ID: 19029193
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in nucleotide excision repair genes xpa, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
    Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. xpa A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
    Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
    Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA repair pathway profiling and microsatellite instability in colorectal cancer.
    Yu J; Mallon MA; Zhang W; Freimuth RR; Marsh S; Watson MA; Goodfellow PJ; McLeod HL
    Clin Cancer Res; 2006 Sep; 12(17):5104-11. PubMed ID: 16951227
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
    Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
    Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.